Clinical Lung Cancer (CLC)

Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

Clinical Lung Cancer (CLC) is :-

• International, Peer-Reviewed, Open Access, Refereed, Cancer Research, Pulmonary and Respiratory Medicine, Oncology, clinical research and mechanistic approaches, drug sensitivity and resistance, gene and antisense therapy, pathology, markers, prognostic indicators, chemoprevention strategies, multimodality therapy, integration of various approaches , Online or Print , Bi-Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1525-7304, E-ISSN: 1938-0690, Established: 2000, Impact Factor: 3.3
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE